Latest Advanz Pharma News & Updates

See the latest news and media coverage for Advanz Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Advanz Pharma

Global specialty, hospital, and rare-disease pharmaceutical company

advanzpharma.com

Headquarters: London, United Kingdom
Company type: Public company
Number of employees: 700–1,000

Last updated Today

Latest news about Advanz Pharma

In short: Advanz Pharma expanded its European biosimilar portfolio through partnerships and acquisitions, despite facing regulatory hurdles and legal fines.

Company announcements

January 30 Advanz Pharma

ADVANZ PHARMA announces patent settlement for Eylea biosimilar

Alvotech settles with Regeneron and Bayer, enabling marketing from January 2026 in UK and May 2026 in EEA and Switzerland.

18 December 2025 Advanz Pharma

Advanz Pharma expands portfolio via acquisition

It acquires additional EMEA rights and global hospital medicine rights, strengthening global footprint and commitment to specialty medicines.

18 December 2025 Advanz Pharma

Advanz Pharma acquires Progynova, Cyclo-Progynova in EMEA, Ilomedin globally

Progynova treats estrogen deficiency; Cyclo-Progynova regulates menstruation. Ilomedin addresses cardiovascular disorders including rare Thromboangiitis Obliterans. Deals expand specialty brands portfolio following prior Latin America and APAC acquisitions.

20 November 2025 Advanz Pharma

Advanz Pharma announces EC approval for Gobivaz

The EC granted marketing authorizations for the biosimilar Gobivaz (golimumab) across the EEA for multiple indications and formats.

Media coverage

March 16 Concurrences

The UK Competition Authority finds a pharmaceutical company guilty of excessive and unfair pricing for Liothyronine Tablets and imposes £101M fine (Advanz) - Concurrences

UK Competition Authority The England & Wales Court of Appeal upholds the Competition Authority’s £99M fine for charging the NHS excessively high prices for a...

March 12 Pharmaceutical Technology

Advanz Pharma Closes Acquisition of Correvio Pharma | Pharmaceutical Technology

Global pharmaceutical company, Advanz Pharma, has closed its acquisition of specialty pharmaceutical company, Correvio Pharma.

January 14 Pharmaceutical Technology

Nordic Capital Acquires Advanz Pharma for $846 Million | Pharmaceutical Technology

The acquisition of Advanz Pharma by Nordic Capital has now completed, in a deal worth $846 million.

January 8 Pearce IP

German Court Grants PIs Preventing Marketing of Aflibercept Biosimilars by STADA, Hexal, Celltrion and Advanz Pharma

On 8 January 2026, the Munich Regional Court granted Regeneron and Bayer a preliminary injunction (PI) preventing STADA, Hexal,...

Never miss news about Advanz Pharma

Track Advanz Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Advanz Pharma competitors & trending companies

Browse news for competitors to Advanz Pharma and other trending companies.